| #383 |
Paul H. Gruver |
IBM |
1 |
| #383 |
Thomas Marion Ragusa |
— |
1 |
| #383 |
William F. Johnson, Jr. |
Closure Medical |
1 |
| #383 |
Michael T. Ivanitch |
— |
1 |
| #383 |
Kelly Ann Maicon |
— |
1 |
| #383 |
James Richard Maicon |
— |
1 |
| #383 |
Christopher K. Waldon |
IBM |
1 |
| #383 |
Kevin B. Carden |
— |
1 |
| #383 |
Benjamin G. Southern |
Altec Industries |
1 |
| #383 |
Marco Trevino |
— |
1 |
| #383 |
William Gerard Volz |
— |
1 |
| #383 |
Athanasios T. Starogiannis |
— |
1 |
| #383 |
Jerry M. Overton |
— |
1 |
| #383 |
Donald Myers |
Bayer Cropscience |
1 |
| #383 |
David E. D'Amato |
— |
1 |
| #383 |
Mark S. Tillery |
IBM |
1 |
| #383 |
Todd Nelson Cannady |
— |
1 |
| #383 |
James R. Peel |
— |
1 |
| #383 |
Steve Simonelli |
Unknown |
1 |
| #383 |
James Michael Broering |
Novozymes A/S |
1 |
| #383 |
Nicholas M. Trainor |
— |
1 |
| #383 |
Gavin Spencer |
— |
1 |
| #383 |
Kenecia J. Jenkins |
— |
1 |
| #383 |
William M. Thorsen, Jr. |
Siemens Energy & Automation |
1 |
| #383 |
Harvey T. Satterwhite |
Altec Industries |
1 |
| #383 |
Alan K. Young |
Parker-Hannifin |
1 |
| #383 |
Eileen F. Farrell-Mestas |
— |
1 |
| #383 |
Brian C. Bullock |
Glaxo Wellcome |
1 |
| #383 |
Doleci Remidio |
Unknown |
1 |
| #383 |
Irvin B. Erickson, Jr. |
GE |
1 |
| #383 |
Joanna C. King |
— |
1 |
| #383 |
Ray M. Bellinger |
Belden Wire & Cable |
1 |
| #383 |
Kenneth De Paul |
Bell Atlantic Network Services |
1 |
| #383 |
Clifford F. Rey |
— |
1 |
| #383 |
Diane Elaine Pfahlert |
— |
1 |
| #383 |
Alvah Dean Fuqua |
IBM |
1 |
| #383 |
Richard Eugene Deaton |
— |
1 |
| #383 |
David B. Alford |
Kennametal |
1 |
| #383 |
Stephen K. Nilson |
Nortel Networks Limited |
1 |
| #383 |
Ronald W. Thorson |
— |
1 |
| #383 |
Merrie B. Gough |
— |
1 |
| #383 |
Thomas H. Giesy |
— |
1 |
| #383 |
Johann Dreml |
— |
1 |
| #383 |
Carl N. Blodgett |
— |
1 |
| #383 |
James M. Hampton |
— |
1 |
| #383 |
David E. Southworth |
IBM |
1 |